These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3331676)

  • 1. Excretion of mutagens in sweat and faeces of man, and in serum, gastric juice and urine of rats, after oral dosing of niridazole or metronidazole.
    Mohtashamipur E; Norpoth K
    Mutagenesis; 1986 Sep; 1(5):371-4. PubMed ID: 3331676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excretion of mutagens in sweat from humans treated with anti-neoplastic drugs.
    Madsen ES; Larsen H
    Cancer Lett; 1988 Jun; 40(2):199-202. PubMed ID: 3383178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice.
    Legator MS; Connor TH; Stoeckel M
    Science; 1975 Jun; 188(4193):1118-9. PubMed ID: 766186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B; de Serres FJ
    J Environ Pathol Toxicol; 1979; 2(4):1109-18. PubMed ID: 156240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B
    J Toxicol Environ Health; 1978; 4(5-6):815-24. PubMed ID: 153406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenic activity of gastric juice.
    Montes G; Cuello C; Gordillo G; Pelon W; Johnson W; Correa P
    Cancer Lett; 1979 Oct; 7(6):307-12. PubMed ID: 389416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary and faecal mutagenicity in Sprague-Dawley rats dosed with the food mutagens quercetin and rutin.
    Crebelli R; Aquilina G; Falcone E; Carere A
    Food Chem Toxicol; 1987 Jan; 25(1):9-15. PubMed ID: 3817665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of frameshift mutagens in rats caused by passive smoking.
    Mohtashamipur E; Norpoth K; Heger M
    J Cancer Res Clin Oncol; 1984; 108(3):296-301. PubMed ID: 6392303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative importance of bacterial and mammalian nitroreductases for niridazole mutagenesis.
    Blumer JL; Friedman A; Meyer LW; Fairchild E; Webster LT; Speck WT
    Cancer Res; 1980 Dec; 40(12):4599-605. PubMed ID: 6893679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on the detection of mutagenic and genotoxic activity in human faeces: aerobic and anaerobic fluctuation tests with S. typhimurium and E. coli, and the SOS Chromotest.
    Venitt S; Bosworth D
    Mutagenesis; 1986 Jan; 1(1):49-64. PubMed ID: 3325736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity testing of the antiparasitic drug entizol (polfa) in the detection system of Salmonella typhimurium mutants.
    Dobiás L
    Mutat Res; 1980 Feb; 77(2):117-26. PubMed ID: 6990236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of metronidazole and two metabolites to the mutagenic activity detected in urine of treated humans and mice.
    Connor TH; Stoeckel M; Evrard J; Legator MS
    Cancer Res; 1977 Feb; 37(2):629-33. PubMed ID: 318924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the exposure of rats to benzo[a]pyrene by the determination of mutagenic activity in excreta, chromosome aberrations and sister chromatid exchanges in peripheral blood cells, and DNA adducts in peripheral blood lymphocytes and liver.
    Willems MI; Roggeband R; Baan RA; Wilmer JW; de Raat WK; Lohman PH
    Mutagenesis; 1991 Mar; 6(2):151-8. PubMed ID: 2056917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disposition of [14C]metronidazole in rats following vaginal and oral administration.
    Buttar HS; Siddiqui WH; Moffatt JH
    J Pharm Pharmacol; 1979 Aug; 31(8):542-4. PubMed ID: 39996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic activity of urinary pigments from patients on antischistosomal therapy with niridazole.
    Roxe DM; Siew C; Siddiqui F; Lang I; Rao GS
    Mutat Res; 1980 Apr; 77(4):367-70. PubMed ID: 6990254
    [No Abstract]   [Full Text] [Related]  

  • 17. Appearance and reappearance of mutagens in urine from rats after oral administration of direct brown 95, due to coprophagy.
    Bos RP; Koopman JP; Theuws JL; Kennis HM; Henderson PT
    Toxicology; 1986 Apr; 39(1):85-92. PubMed ID: 3515634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Black tea intake modulates the excretion of urinary mutagens in rats exposed to 6-aminochrysene: induction of cytochromes P450 by 6-aminochrysene in the rat.
    Yoxall V; Umachandran M; Wilson J; Kentish P; Ioannides C
    Mutagenesis; 2005 Jan; 20(1):23-8. PubMed ID: 15598702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetic studies of ornidazole and metronidazole in man.
    Schwartz DE; Jeunet F
    Chemotherapy; 1976; 22(1):19-29. PubMed ID: 1253627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of the effect of diet on the mutagenicity of human faeces.
    Venitt S; Bosworth D; Alldrick AJ
    Mutagenesis; 1986 Sep; 1(5):353-8. PubMed ID: 2842576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.